MB, BS, MD, DA, FRCP
Cancers in older patients
I am a Consultant in Medical Oncology at St Bartholomew’s Hospital, London. I am Lead Medical Oncologist for Thoracic Oncology and is Director of Bart’s Mesothelioma Research. I was recently appointed Director of Acute Oncology at St Bartholomew’s Hospital and the Royal London Hospital, reflecting my commitment to high quality in-hospital care for cancer patients.
I trained in Medicine at St George’s Hospital Medical School, University of London. After five years’ postgraduate training in general medicine, anaesthesia and intensive care, I moved to the Royal Marsden Hospital and Institute of Cancer Research to start my oncology career in 1994. There I undertook research into lung cancer, brain tumours and leukaemia, for which I was awarded a Doctor of Medicine (MD) degree under the supervision of Professor Ray Powles. I completed my oncology training at St Bartholomew’s Hospital. I have been a visiting fellow at Harvard Medical School (in 1999) and New England Medical Center (in 1994), both in Boston, USA.
I am well known in the UK as a specialist in lung cancer, and am internationally recognized for my work in malignant mesothelioma. This was acknowledged in 2004 when I was elected to the Board of Directors of the International Mesothelioma Group in Philadelphia. Since 2010 I have been Secretary of the International Mesothelioma Group.
I am also interested in complex and rare tumours, cancers of unknown primary site, and in cancers in the older patient. I have published research papers in the Journal of Clinical Oncology, Cancer, Thorax, the Lancet and other journals. I have authored numerous book chapters on cancer topics. I am frequently invited to lecture at academic meetings and patient support groups, both in the UK and abroad.
I have a longstanding commitment to patient advocacy and have successfully lobbied the NHS and NICE on the provision of new cancer treatments. I am Chair of the advisory board of Macmillan Mesothelioma UK, an information service for patients and families affected by asbestos-related cancer.
My primary aim is to provide outstanding and compassionate care for people and families affected by cancer. State-of-the-art treatment, psychological support and open communication are my priorities when taking care of his patients.